Salt Lake City, UT, United States of America

Benjamin Judson Sukow

This inventor holds 1 USPTO granted patent. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Benjamin Judson Sukow

Introduction

Benjamin Judson Sukow is a notable inventor based in Salt Lake City, UT. He has made significant contributions to the field of biotechnology, particularly in the design of cell-based screening assays. His innovative approach has the potential to enhance the efficiency and effectiveness of experimental designs in medical research.

Latest Patents

Sukow holds a patent for "Methods and user interfaces for designing cell-based screening assay experiments." This patent describes a method that involves a graphical user interface for designing experiments. The process includes receiving inputs that define template plate definitions, disease reagents, treatment reagents, and their respective concentrations. The method ultimately generates a design for the experiment, determining the number of test wells required and distributing them across test plates.

Career Highlights

Currently, Benjamin Judson Sukow is employed at Recursion Pharmaceuticals, Inc. His work at this innovative company focuses on leveraging technology to improve drug discovery and development processes. Sukow's expertise in designing assays is crucial for advancing research in the pharmaceutical industry.

Collaborations

Sukow collaborates with talented individuals such as Adam Smith Murray and Anthus John Williams. These partnerships enhance the innovative environment at Recursion Pharmaceuticals, fostering creativity and progress in their projects.

Conclusion

Benjamin Judson Sukow's contributions to the field of biotechnology through his patent and work at Recursion Pharmaceuticals exemplify the impact of innovation in medical research. His efforts are paving the way for more efficient experimental designs that can lead to significant advancements in drug discovery.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…